BACKGROUND: Daytime and nighttime sleep disturbances and cognitive impairment occur frequently in Parkinson's disease (PD), but little is known about the interdependence of these non-motor complications. Thus, we examined the relationships among excessive daytime sleepiness, nighttime sleep quality and cognitive impairment in PD, including severity and specific cognitive deficits. METHODS: Ninety-three PD patients underwent clinical and neuropsychological evaluations including the Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). Patients were classified as having normal cognition (PD-NC), mild cognitive impairment (PD-MCI), or dementia (PDD) using recently proposed Movement Disorder Society PD-MCI and PDD criteria. Relationships between the sleep and cognitive measures and PD cognitive groups were examined. RESULTS: The PD cohort included PD-NC (n = 28), PD-MCI (n = 40), and PDD (n = 25) patients. ESS scores, as a measure of daytime sleepiness, were significantly worse (p = 0.005) in cognitively impaired PD patients, particularly PDD patients. ESS scores correlated significantly with Mini-Mental State Examination scores and also with cognitive domain scores for attention/working memory, executive function, memory, and visuospatial function. In contrast, PSQI scores, as a measure of nighttime sleep quality, neither differed among cognitive groups nor correlated with any cognitive measures. CONCLUSIONS: Daytime sleepiness in PD, but not nighttime sleep problems, is associated with cognitive impairment in PD, especially in the setting of dementia, and attention/working memory, executive function, memory, and visuospatial deficits. The presence of nighttime sleep problems is pervasive across the PD cognitive spectrum, from normal cognition to dementia, and is not independently associated with cognitive impairment or deficits in cognitive domains.
BACKGROUND: Daytime and nighttime sleep disturbances and cognitive impairment occur frequently in Parkinson's disease (PD), but little is known about the interdependence of these non-motor complications. Thus, we examined the relationships among excessive daytime sleepiness, nighttime sleep quality and cognitive impairment in PD, including severity and specific cognitive deficits. METHODS: Ninety-three PDpatients underwent clinical and neuropsychological evaluations including the Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). Patients were classified as having normal cognition (PD-NC), mild cognitive impairment (PD-MCI), or dementia (PDD) using recently proposed Movement Disorder Society PD-MCI and PDD criteria. Relationships between the sleep and cognitive measures and PD cognitive groups were examined. RESULTS: The PD cohort included PD-NC (n = 28), PD-MCI (n = 40), and PDD (n = 25) patients. ESS scores, as a measure of daytime sleepiness, were significantly worse (p = 0.005) in cognitively impaired PDpatients, particularly PDDpatients. ESS scores correlated significantly with Mini-Mental State Examination scores and also with cognitive domain scores for attention/working memory, executive function, memory, and visuospatial function. In contrast, PSQI scores, as a measure of nighttime sleep quality, neither differed among cognitive groups nor correlated with any cognitive measures. CONCLUSIONS:Daytime sleepiness in PD, but not nighttime sleep problems, is associated with cognitive impairment in PD, especially in the setting of dementia, and attention/working memory, executive function, memory, and visuospatial deficits. The presence of nighttime sleep problems is pervasive across the PD cognitive spectrum, from normal cognition to dementia, and is not independently associated with cognitive impairment or deficits in cognitive domains.
Authors: Ronald B Postuma; Isabelle Arnulf; Birgit Hogl; Alex Iranzo; Tomoyuki Miyamoto; Yves Dauvilliers; Wolfgang Oertel; Yo-El Ju; Monica Puligheddu; Poul Jennum; Amelie Pelletier; Christina Wolfson; Smaranda Leu-Semenescu; Birgit Frauscher; Masayuki Miyamoto; Valerie Cochen De Cock; Marcus M Unger; Karin Stiasny-Kolster; Maria Livia Fantini; Jacques Y Montplaisir Journal: Mov Disord Date: 2012-05-30 Impact factor: 10.338
Authors: I Arnulf; E Konofal; M Merino-Andreu; J L Houeto; V Mesnage; M L Welter; L Lacomblez; J L Golmard; J P Derenne; Y Agid Journal: Neurology Date: 2002-04-09 Impact factor: 9.910
Authors: Sebastian Paus; Hans Michael Brecht; Jürgen Köster; Gert Seeger; Thomas Klockgether; Ullrich Wüllner Journal: Mov Disord Date: 2003-06 Impact factor: 10.338
Authors: Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins Journal: Mov Disord Date: 2013-10-09 Impact factor: 10.338
Authors: Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton Journal: J Clin Exp Neuropsychol Date: 2019-06-10 Impact factor: 2.475
Authors: Jennifer G Goldman; Glenn T Stebbins; Vania Leung; Barbara C Tilley; Christopher G Goetz Journal: Parkinsonism Relat Disord Date: 2014-08-13 Impact factor: 4.891
Authors: Brittany Rohl; Kathleen Collins; Sarah Morgan; Stephanie Cosentino; Edward D Huey; Elan D Louis Journal: J Neurol Sci Date: 2016-10-08 Impact factor: 3.181
Authors: Zheng Zhong; Douglas Merkitch; M Muge Karaman; Jiaxuan Zhang; Yi Sui; Jennifer G Goldman; Xiaohong Joe Zhou Journal: Radiology Date: 2019-02-19 Impact factor: 11.105
Authors: David R Shprecher; Charles H Adler; Nan Zhang; Holly A Shill; Christine M Belden; Erika Driver-Dunckley; Shyamal H Mehta; Kathryn J Davis; Lucia I Sue; Edward Zamrini; Thomas G Beach Journal: Clin Neurol Neurosurg Date: 2020-02-06 Impact factor: 1.876
Authors: Jennifer G Goldman; Glenn T Stebbins; Vy Dinh; Bryan Bernard; Doug Merkitch; Leyla deToledo-Morrell; Christopher G Goetz Journal: Brain Date: 2014-01-29 Impact factor: 13.501
Authors: Jennifer G Goldman; Samantha Holden; Bichun Ouyang; Bryan Bernard; Christopher G Goetz; Glenn T Stebbins Journal: Mov Disord Date: 2014-12-01 Impact factor: 10.338